Kimuraet al.,Science 367 , eaaw8429 (2020) 28 February 2020 5of12
0410Relative mRNA expression(Ins2/18S)862* ****Propionate
PA-1Non-targeting siRNA
Gpr43 siRNA-+- -
--+ -Differentiation --- ++++++++++NS
NSNSDEF
**00.522.5Mo E18.5Insulin (n g/mL)1.5
101234Relative mRNAexpression(genes/18S)012** ** 3Nkx6.1
** **Ins20248Pancreatic insulin(ng/mg tissues)6* **0100200300400Insulin+
fluorescence intensity / DAPI (%)Differentiation******050150200Mo E18.5Plasma glucose (mg/dL)100BAC01235Relative mRNAexpression(genes/18S)** **Pax4401234
** **Pax600.511.5
** **Gcg01235Colonic total GLP-1(pmol/mg tissues)4** *050100150200GLP -1+ cells
in organoids (%)*WT
Gpr43-/-01234Relative mRNAexpression(Gcg/18S)** ** ** NS01234WT Gpr43-/-Propionate(+)(-) (+)(-)
PropionateGLP-1DAPIMerge50 μm(-) PropionateWT
(-)Gpr43-/-
Propionate(-)InsulinDAPIMergePropionate PA-1 (-) Propionate PA-1Differentiation50 μmFig. 4. Propionate promotes enteroendocrine and pancreaticbcell differ-
entiation via embryonic GPR43.(A)Pax4,Pax6, andGcgmRNA expression
and GLP-1 protein levels in the colon (E18.5) (n= 7 or 8 tissues of embryos from
three litters per group). (BandC) Expression ofGcg(B) and distribution of GLP-1–
positive cells (C) after 24-hour treatment of embryonic organoids (E15.5) in the
presence (+) or absence (-) of Wnt with GPR43 ligands [1 and 10 mM (B); 100mM
propionate (C)]. GLP-1, green; DAPI, blue;n= 5 to 7 independent experiments from
two biological replicates per condition. (D) Expression ofNkx6.1andIns2mRNA
and insulin protein levels in the mouse pancreas (E18.5) (n= 7 or 8 tissues of
embryos from three litters per group). (E) Expression ofIns2(left) and localization
(middle; immunostaining) of insulin, and insulin positive cell count (right) in the
presence or absence of GPR43 ligands (10mM PA-1, 1 mM propionate) after
72-hour treatment (insulin, green; DAPI, blue;n= 4 to 10 independent experiments
from two or three biological replicates per condition). For induction ofbcell
differentiation, cells were cultured with betacellulin and activin A. (F) Plasma insulin
(left) and plasma glucose (right) levels in mothers and embryos of E18.5 (n=8plasma
samples andn= 8 plasma samples of embryos from eight litters per group). GF
and SPF mice with C57BL/6J background were analyzed [(A), (D), and (F)].
Student’sttest [(A), (D), and (F)] and Tukey–Kramer’s test [(B) and (E)]; **P<
0.01 and *P< 0.05. NS, not significant. All data are presented as means ± SEM.RESEARCH | RESEARCH ARTICLE